| Growth differentiation factor 15, ST2, high-sensitivity troponin T, and N-terminal pro brain natriuretic peptide in heart failure with preserved vs. reduced ejection fraction. | |
| | |
MedLine Citation:
|
PMID: 22869458 Owner: NLM Status: Publisher |
Abstract/OtherAbstract:
|
AIMS: Growth differentiation factor 15 (GDF15), ST2, high-sensitivity troponin T (hsTnT), and N-terminal pro brain natriuretic peptide (NT-proBNP) are biomarkers of distinct mechanisms that may contribute to the pathophysiology of heart failure (HF) [inflammation (GDF15); ventricular remodelling (ST2); myonecrosis (hsTnT); and wall stress (NT-proBNP)]. METHODS AND RESULTS: We compared circulating levels of GDF15, ST2, hsTnT, and NT-proBNP, as well as their combinations, in compensated patients with clinical HF with reduced ejection fraction (HFREF) (n = 51), HF with preserved ejection fraction (HFPEF) (n= 50), and community-based controls (n = 50). Compared with controls, patients with HFPEF and HFREF had higher median levels of GDF15 (540 pg/mL vs. 2529 and 2672 pg/mL, respectively), hsTnT (3.7 pg/mL vs. 23.7 and 35.6 pg/mL), and NT-proBNP (69 pg/mL vs. 942 and 2562 pg/mL), but not ST2 (27.6 ng/mL vs. 31.5 and 35.3 ng/mL), adjusting for clinical covariates. In receiver operating characteristic curve analyses, NT-proBNP distinguished HFREF from controls with an area under the curve (AUC) of 0.987 (P < 0.001); GDF15 distinguished HFPEF from controls with an AUC of 0.936 (P < 0.001); and the combination of NT-proBNP and GDF15 distinguished HFPEF from controls with an AUC of 0.956 (P < 0.001). NT-proBNP and hsTnT levels were higher in HFREF than in HFPEF (adjusted P < 0.04). The NT-proBNP:GDF15 ratio distinguished between HFPEF and HFREF with the largest AUC (0.709; P < 0.001). CONCLUSIONS: Our study provides comparative data on physiologically distinct circulating biomarkers in HFPEF, HFREF, and controls from the same community. These data suggest a prominent role for myocardial injury (hsTnT) with increased wall stress (NT-proBNP) in HFREF, and systemic inflammation (GDF15) in HFPEF. |
| | |
Authors:
|
Rajalakshmi Santhanakrishnan; Jenny P C Chong; Tze P Ng; Lieng H Ling; David Sim; Kui Toh G Leong; Poh Shuan D Yeo; Hean Y Ong; Fazlur Jaufeerally; Raymond Wong; Ping Chai; Adrian F Low; Arthur Mark Richards; Carolyn S P Lam |
Related Documents
:
|
16705468 - Beta1-adrenergic receptor antagonism abrogates cardioprotective effects of intermittent... 7446428 - Lidocaine-induced reduction in size of experimental myocardial infarction. 22157548 - What we should know about the cellular and tissue response causing catheter obstruction... 22707158 - Cardiac-generated prostanoids mediate cardiac myocyte apoptosis after myocardial ischae... 2354508 - Orion, an improved balloon on a wire system: initial experience. 21913208 - Relationship between left ventricular dyssynchrony and reverse remodeling after cardiac... |
Publication Detail:
|
Type: JOURNAL ARTICLE Date: 2012-8-5 |
Journal Detail:
|
Title: European journal of heart failure Volume: - ISSN: 1879-0844 ISO Abbreviation: Eur. J. Heart Fail. Publication Date: 2012 Aug |
Date Detail:
|
Created Date: 2012-8-7 Completed Date: - Revised Date: - |
Medline Journal Info:
|
Nlm Unique ID: 100887595 Medline TA: Eur J Heart Fail Country: - |
Other Details:
|
Languages: ENG Pagination: - Citation Subset: - |
Affiliation:
|
Cardiovascular Research Institute, National University of Singapore, Singapore. |
Export Citation:
|
APA/MLA Format Download EndNote Download BibTex |
| MeSH Terms | |
Descriptor/Qualifier:
|
|
From MEDLINE®/PubMed®, a database of the U.S. National Library of Medicine
Previous Document: Coronary telangiectasia associated with hypertrophic cardiomyopathy.
Next Document: Plasma endothelin-1 and vascular endothelial growth factor levels and their relationship to hemodyna...